Skip to content

Mustafeez Ur Rahman, MD

NPI 1174175376ActiveIndividual· Internal Medicine, Interventional Cardiology· Mobile, AL

Internal Medicine, Interventional Cardiology (MD) in Mobile, Alabama, licensed in AL, with an NPI issued in July 2019. Part D covered 208 prescriptions written in 2024, 88% of them generic. Abbott Laboratories was the largest of 19 companies reporting payments in 2025, $6,895 in all, mostly grants.

Overview

NPI1174175376
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedJul 9, 2019
Last updated in NPPESSep 14, 2026
Certified by providerSep 14, 2026

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Interventional Cardiology Primary207RI0011XMD.45795AL

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Internal Medicine (AL)

Part D prescriptions in 2024

Prescriptions (claims)208 · 483 30-day fills
Patients42
Total drug cost$24,287
Generic share88% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$6,895 · 52 payments from 19 companies
  • 2024$84.91 · 3 payments from 3 companies

Top paying companies in 2025

What the 2025 payments were for

  • Grant$4,667 · 2 payments
  • Food and Beverage$2,228 · 50 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other interventional cardiologists in Mobile

All 23 interventional cardiologists in Mobile · All interventional cardiologists in Alabama